A phase II trial of induction cisplatin, 5-FU leucovorin, and interferon a-2B (PFL-a) followed by concurrent hydroxyurea, 5-FU and radiation for stage IV squamous cell cancers of the head and neck (HNC)

M.S. Kies, D.J. Haraf, B.B. Mittal, I. Athanasiadis, M. Kozloff, J. McEvilly, R. Mick, W. Moran, W. Panje, H. Pelzer

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)207-210
Number of pages4
JournalIn: Cancer Treatment: An Update
StatePublished - 1994

Cite this